68 related articles for article (PubMed ID: 38504247)
21. Identifying Adherence Patterns Across Multiple Medications and Their Association With Health Outcomes in Older Community-Dwelling Adults With Multimorbidity.
Walsh CA; Bennett KE; Wallace E; Cahir C
Value Health; 2020 Aug; 23(8):1063-1071. PubMed ID: 32828219
[TBL] [Abstract][Full Text] [Related]
22. Treatment patterns, healthcare resource utilization, and costs among patients with idiopathic pulmonary fibrosis treated with antifibrotic medications in US-based commercial and Medicare Supplemental claims databases: a retrospective cohort study.
Corral M; DeYoung K; Kong AM
BMC Pulm Med; 2020 Jul; 20(1):188. PubMed ID: 32652979
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal Medication Adherence in Older Adults With Multimorbidity and Association With Health Care Utilization: Results From the Irish Longitudinal Study on Ageing.
Walsh CA; Cahir C; Bennett KE
Ann Pharmacother; 2021 Jan; 55(1):5-14. PubMed ID: 32608252
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis.
Richeldi L; Kolb M; Jouneau S; Wuyts WA; Schinzel B; Stowasser S; Quaresma M; Raghu G
BMC Pulm Med; 2020 Jan; 20(1):3. PubMed ID: 31914963
[TBL] [Abstract][Full Text] [Related]
25. The association between medication non-adherence and adverse health outcomes in ageing populations: A systematic review and meta-analysis.
Walsh CA; Cahir C; Tecklenborg S; Byrne C; Culbertson MA; Bennett KE
Br J Clin Pharmacol; 2019 Nov; 85(11):2464-2478. PubMed ID: 31486099
[TBL] [Abstract][Full Text] [Related]
26. Clinical Effectiveness of Antifibrotic Medications for Idiopathic Pulmonary Fibrosis.
Dempsey TM; Sangaralingham LR; Yao X; Sanghavi D; Shah ND; Limper AH
Am J Respir Crit Care Med; 2019 Jul; 200(2):168-174. PubMed ID: 31150266
[No Abstract] [Full Text] [Related]
27. The association between pharmacy refill-adherence metrics and healthcare utilisation: a prospective cohort study of older hypertensive adults.
Dillon P; Smith SM; Gallagher P; Cousins G
Int J Pharm Pract; 2019 Oct; 27(5):459-467. PubMed ID: 30968988
[TBL] [Abstract][Full Text] [Related]
28. Retrospective Analysis of Medication Utilization and Clinical Outcomes in Patients With Idiopathic Pulmonary Fibrosis Treated With Nintedanib or Pirfenidone.
Ipatova AY; Koerner PH; Miller RT; Staskon F; Radi M
Clin Med Insights Circ Respir Pulm Med; 2019; 13():1179548419834922. PubMed ID: 30890862
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Raghu G; Remy-Jardin M; Myers JL; Richeldi L; Ryerson CJ; Lederer DJ; Behr J; Cottin V; Danoff SK; Morell F; Flaherty KR; Wells A; Martinez FJ; Azuma A; Bice TJ; Bouros D; Brown KK; Collard HR; Duggal A; Galvin L; Inoue Y; Jenkins RG; Johkoh T; Kazerooni EA; Kitaichi M; Knight SL; Mansour G; Nicholson AG; Pipavath SNJ; Buendía-Roldán I; Selman M; Travis WD; Walsh S; Wilson KC;
Am J Respir Crit Care Med; 2018 Sep; 198(5):e44-e68. PubMed ID: 30168753
[TBL] [Abstract][Full Text] [Related]
30. Idiopathic Pulmonary Fibrosis.
Lederer DJ; Martinez FJ
N Engl J Med; 2018 May; 378(19):1811-1823. PubMed ID: 29742380
[No Abstract] [Full Text] [Related]
31. A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis.
Harari S; Caminati A; Poletti V; Confalonieri M; Gasparini S; Lacedonia D; Luppi F; Pesci A; Sebastiani A; Spagnolo P; Vancheri C; Balestro E; Bonifazi M; Cerri S; De Giacomi F; Della Porta R; Foschino Barbaro MP; Fui A; Pasquinelli P; Rosso R; Tomassetti S; Specchia C; Rottoli P;
Respiration; 2018; 95(6):433-440. PubMed ID: 29587263
[TBL] [Abstract][Full Text] [Related]
32. Economic impact of medication non-adherence by disease groups: a systematic review.
Cutler RL; Fernandez-Llimos F; Frommer M; Benrimoj C; Garcia-Cardenas V
BMJ Open; 2018 Jan; 8(1):e016982. PubMed ID: 29358417
[TBL] [Abstract][Full Text] [Related]
33. First Data on Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Forced Vital Capacity of ≤50 % of Predicted Value.
Wuyts WA; Kolb M; Stowasser S; Stansen W; Huggins JT; Raghu G
Lung; 2016 Oct; 194(5):739-43. PubMed ID: 27377558
[TBL] [Abstract][Full Text] [Related]
34. Trajectories of Diabetes Medication Adherence and Hospitalization Risk: A Retrospective Cohort Study in a Large State Medicaid Program.
Lo-Ciganic WH; Donohue JM; Jones BL; Perera S; Thorpe JM; Thorpe CT; Marcum ZA; Gellad WF
J Gen Intern Med; 2016 Sep; 31(9):1052-60. PubMed ID: 27229000
[TBL] [Abstract][Full Text] [Related]
35. The association between trajectories of endocrine therapy adherence and mortality among women with breast cancer.
Winn AN; Dusetzina SB
Pharmacoepidemiol Drug Saf; 2016 Aug; 25(8):953-9. PubMed ID: 27125337
[TBL] [Abstract][Full Text] [Related]
36. Association between trajectories of buprenorphine treatment and emergency department and in-patient utilization.
Lo-Ciganic WH; Gellad WF; Gordon AJ; Cochran G; Zemaitis MA; Cathers T; Kelley D; Donohue JM
Addiction; 2016 May; 111(5):892-902. PubMed ID: 26662858
[TBL] [Abstract][Full Text] [Related]
37. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review.
Raghu G; Amatto VC; Behr J; Stowasser S
Eur Respir J; 2015 Oct; 46(4):1113-30. PubMed ID: 26424523
[TBL] [Abstract][Full Text] [Related]
38. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
Raghu G; Rochwerg B; Zhang Y; Garcia CA; Azuma A; Behr J; Brozek JL; Collard HR; Cunningham W; Homma S; Johkoh T; Martinez FJ; Myers J; Protzko SL; Richeldi L; Rind D; Selman M; Theodore A; Wells AU; Hoogsteden H; Schünemann HJ; ; ; ;
Am J Respir Crit Care Med; 2015 Jul; 192(2):e3-19. PubMed ID: 26177183
[TBL] [Abstract][Full Text] [Related]
39. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review.
Hutchinson J; Fogarty A; Hubbard R; McKeever T
Eur Respir J; 2015 Sep; 46(3):795-806. PubMed ID: 25976683
[TBL] [Abstract][Full Text] [Related]
40. Association between trajectories of statin adherence and subsequent cardiovascular events.
Franklin JM; Krumme AA; Tong AY; Shrank WH; Matlin OS; Brennan TA; Choudhry NK
Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1105-13. PubMed ID: 25903307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
